Lipid droplets are a metabolic vulnerability in melanoma.
Dianne Lumaquin-YinEmily MontalEleanor JohnsArianna BaggioliniTing-Hsiang HuangYilun MaCharlotte LaPlanteShruthy SureshLorenz StuderRichard M WhitePublished in: Nature communications (2023)
Melanoma exhibits numerous transcriptional cell states including neural crest-like cells as well as pigmented melanocytic cells. How these different cell states relate to distinct tumorigenic phenotypes remains unclear. Here, we use a zebrafish melanoma model to identify a transcriptional program linking the melanocytic cell state to a dependence on lipid droplets, the specialized organelle responsible for lipid storage. Single-cell RNA-sequencing of these tumors show a concordance between genes regulating pigmentation and those involved in lipid and oxidative metabolism. This state is conserved across human melanoma cell lines and patient tumors. This melanocytic state demonstrates increased fatty acid uptake, an increased number of lipid droplets, and dependence upon fatty acid oxidative metabolism. Genetic and pharmacologic suppression of lipid droplet production is sufficient to disrupt cell cycle progression and slow melanoma growth in vivo. Because the melanocytic cell state is linked to poor outcomes in patients, these data indicate a metabolic vulnerability in melanoma that depends on the lipid droplet organelle.
Keyphrases
- single cell
- fatty acid
- rna seq
- cell cycle
- high throughput
- cell therapy
- skin cancer
- cell proliferation
- endothelial cells
- dna methylation
- end stage renal disease
- climate change
- induced apoptosis
- genome wide
- cell death
- palliative care
- peritoneal dialysis
- type diabetes
- cell cycle arrest
- newly diagnosed
- patient reported outcomes
- data analysis